- Report
- February 2024
- 147 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- February 2024
- 120 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- April 2023
- 111 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- February 2024
- 120 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- February 2024
- 115 Pages
Global
From €4261EUR$4,750USD£3,643GBP
- Report
- July 2025
- 236 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- December 2024
- 207 Pages
Global
From €2243EUR$2,500USD£1,917GBP
- Report
- April 2024
- 181 Pages
Global
From €4037EUR$4,500USD£3,451GBP
- Report
- June 2022
- 73 Pages
Global
From €1749EUR$1,950USD£1,495GBP
- Report
- November 2024
- 66 Pages
Global
From €1749EUR$1,950USD£1,495GBP
- Report
- January 2025
- 140 Pages
Global
From €3543EUR$3,950USD£3,029GBP
- Report
- August 2023
- 215 Pages
Global
€4301EUR$4,795USD£3,677GBP
- Report
- March 2025
- 136 Pages
Global
From €4481EUR$4,995USD£3,831GBP
- Report
- September 2019
- 119 Pages
Global
From €4440EUR$4,950USD£3,796GBP
- Report
- August 2025
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- December 2024
- 150 Pages
Global
From €2835EUR$3,160USD£2,423GBP
€3543EUR$3,950USD£3,029GBP
- Report
- February 2026
- 150 Pages
Canada
From €4351EUR$4,850USD£3,719GBP
- Report
- February 2026
- 150 Pages
Germany
From €4351EUR$4,850USD£3,719GBP
- Report
- December 2024
- 150 Pages
Global
From €4351EUR$4,850USD£3,719GBP
- Report
- September 2024
- 150 Pages
Global
From €4351EUR$4,850USD£3,719GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more